Abstract
Nasopharyngeal carcinoma (NPC) accounts for less than 1 % of all paediatric cancers. Advances in imaging, radiation delivery, chemotherapy and improvement in multidisciplinary care have resulted in drastic changes in the outcome of this disease. Since NPC is extremely rare in paediatric population and there is paucity of data in Indian patients, we conducted the present study to analyze the outcome of paediatric NPC. Eighteen patients aged 18 years or less, who had pathologically proven diagnosis of NPC and had received treatment at our institute from 2003 to 2010 was included for analysis. These patients were treated with radiotherapy and chemotherapy. Event free survival, local and systemic relapse and progression were analysed. These outcomes were correlated with age, radiation dose and the stage of disease. Majority of patients presented with advanced stage and poor histological grade (94.4 % had WHO Type III disease). The median follow up was 38 months (range 3–91 months). The estimated event free survival at a follow up of 5 years was 64.28 %. Distant metastasis at presentation and lower radiation dose were predictive of poor outcome. Paediatric NPC usually presents in an advanced stage. Our results are comparable to studies which have used only chemoradiotherapy, are far inferior to studies which have used chemoradiotherapy and adjuvant immunotherapy. Larger prospective studies are required to define the role of adjuvant immunotherapy, the optimum dose and schedule of chemoradiotherapy and role of new agents like cetuximab in Indian paediatric patients.
Similar content being viewed by others
References
Spano JP, Busson P, Atlan D et al (2003) Nasopharyngeal carcinomas: an update. Eur J Cancer 39:2121–2135
Lee AW, Law SC, Foo W, Poon YF, Chan DK, O SK, Tung SY, Cheung FK, Thaw M, Ho JH (1993) Nasopharyngeal carcinoma: local control by megavoltage irradiation. Br J Radiol 66(786):528–536
Wolff HA, Rodel RMW, Gunawan B, Overbeck T, Herrmann MKA, Hennies S et al (2010) Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferonbeta in undifferentiated carcinomas. J Cancer Res Clin Oncol 136:89–97
Mertens R, Granzen B, Lassay L, Bucsky P, Hundgen M, Stetter G, Heimann G, Weiss C, Hess CF, Gademann G (2005) Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH). Cancer 104:1083–1089
Ahmad A, Stefani S (1986) Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients. J Surg Oncol 33(3):194–197
Li J-X, Lu T-X, Ying H, Fei H (2012) Clinical characteristics of recurrent nasopharyngeal carcinoma in high-incidence area. Sci World J 2012:8. doi:10.1100/2012/719754
Rodriguez-Galindo C, Wofford M, Castleberry RP et al (2005) Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovarin for paediatric nasopharyngeal carcinoma. Cancer 103:850–857
Ozyar E, Selek U, Laskar S et al (2006) Treatment results of 165 paediatric patients with non-metastatic nasopharyngeal carcinoma: a rare cancer network study. Radiother Oncol 81:39–46
Vokes EE, Liebowitz DN, Weichselbaum RR (1997) Nasopharyngeal carcinoma. Lancet 350:1087–1091
Ayan I, Altun M (1996) Nasopharyngeal carcinoma in children: retrospective review of 50 patients. Int J Radiat Oncol Biol Phys 35:485–492
Cvitkovic E, Bachouchi M, Armand JP (1991) Nasopharyngeal carcinoma: biology, natural history and therapeutic implications. Hematol Oncol Clin North Am 5:821–823
Fandi A, Bachouchi M, Azli N et al (2000) Long term disease free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol 18:1324–1330
Ingersoll L, Woo SY, Donaldson S, Giesler J, Maor MH, Goffinet D, Cangir A, Goepfert H, Oswald MJ, Peters LJ (1990) Nasopharyngeal carcinoma in the young: a combined M.D. Anderson and Stanford experience. Int J Radiat Oncol Biol Phys 19(4):881–887
Laskar S, Vimal S, Muckaden MA, Laskar S, Bhalla V, Banavali S, Kurkure P, Nair CN, Dinshaw KA (2004) Nasopharyngeal carcinoma in children: ten years experience at the tata memorial hospital, Mumbai. Int. J of Radiat Oncol Biol Phys 58(1):189–195
Laskar S, Bahl G, Muckaden MA et al (2008) Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 72(3):728–736
Langendijk JA, Leemans ChR, Buter J et al (2004) The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 22(22):4604–4612
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guruprasad, B., Tanvir, P., Rohan, B. et al. Paediatric Nasopharyngeal Carcinoma: An 8-Year Study from a Tertiary Care Cancer Centre in South India. Indian J Otolaryngol Head Neck Surg 65 (Suppl 1), 131–134 (2013). https://doi.org/10.1007/s12070-013-0622-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-013-0622-1